Day: December 22, 2020

PRESS RELEASE                                                                                                                                  Kiruna on 22 December 2020NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, JAPAN, CANADA, SOUTH AFRICA, NEW ZEALAND SINGAPORE HONG KONG, SWITZERLAND OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE ILLEGAL OR REQUIRE FURTHER REGISTRATION OR OTHER MEASURES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES OF COPPERSTONE RESOURCES AB (PUBL). PLEASE REFER TO THE SECTION “IMPORTANT INFORMATION” BELOW.The board of directors of Copperstone Resources AB (publ) (“Copperstone” or the “Company”) has today, by virtue of the authorisation of the EGM of 15 December 2020, resolved upon a...

PRESSMEDDELANDE                                                                                                                       Kiruna den 22 december 2020EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I USA, AUSTRALIEN, JAPAN, KANADA, SYDAFRIKA, NYA ZEELAND, SINGAPORE, HONGKONG, SCHWEIZ ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG ELLER KRÄVA YTTERLIGARE REGISTRERINGS- ELLER ANDRA ÅTGÄRDER. DETTA PRESSMEDDELANDE UTGÖR INTE ETT ERBJUDANDE OM NÅGRA VÄRDEPAPPER FRÅN COPPERSTONE RESOURCES AB (PUBL). SE AVSNITTET “VIKTIG INFORMATION” NEDAN.Styrelsen i Copperstone Resources AB (publ) (“Copperstone” eller “Bolaget”) har idag, med stöd från bemyndigandet från den extra bolagsstämman den 15 december...

ROCKVILLE, MD, Dec. 22, 2020 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced the publication of a manuscript on MGD019, an investigational PD-1 × CTLA-4 bispecific DART molecule, in Cell Reports Medicine.  MacroGenics’ DART platform allows for the creation of bispecific antibody-based molecules with the ability to bind to two distinct targets in contrast to a single target as supported by traditional monoclonal antibodies. The publication, Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule, highlights key findings from the ongoing Phase 1 trial of MGD019 first-in-human study of patients with advanced solid tumors...

 22 December 2020 17:30 CETArcelorMittal announces the extension of the conversion date for the $1 billion privately placed mandatory convertible bond (MCB) issued on 28 December 2009 by one of its wholly-owned Luxembourg subsidiaries.This amendment to the MCB, which is mandatorily convertible into preferred shares of such subsidiary, was executed on 22 December 2020. The mandatory conversion date of the bond has been extended to 31 January 2024. The other main features of the MCB remain unchanged. The bond was placed privately with Credit Agricole Corporate and Investment Bank and is not listed.The subsidiary has simultaneously executed amendments providing for the extension of the outstanding notes into which it invested the proceeds of the bond issuance, which are linked to shares of the listed company China Oriental Group Company...

LiiteOVARO_22.12_trades

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (the “Company” or “Clear Blue”) (TSXV:CBLU) (Frankfurt:OYA) is pleased to announce that it has closed its upsized and oversubscribed private placement, including a full exercise of the agent’s option (the “Offering”), for gross proceeds of approximately CAD$5.0 million. Echelon Wealth Partners Inc. (the “Agent”) acted as Agent and sole bookrunner for the Offering.The Offering resulted in the issuance of 13,157,800 units of the Company (each, a “Unit” and collectively the “Units”) at a price of C$0.38 per Unit. Each Unit consists of one common share in the capital of the Company (each, a “Common Share” and collectively the “Common Shares”) and one-half...

WARSAW, Ind., Dec. 22, 2020 (GLOBE NEWSWIRE) — Lakeland Financial Corporation ranked seventh overall, and in the top ten in six of ten categories in Bank Director Magazine’s 2021 RankingBanking Performance Powerhouses study.The study, published December 14, 2020, and sponsored by Crowe LLP, featured 20 banks that have delivered long-term value for their shareholders over time. Bank Director selected high-performing banks based on total shareholder return generated over a 20-year period ending June 30, 2020. Banks ranking in the top 20 for high performance varied in size, business model, strengths and geography. According to Bank Director Magazine, their common trait was a track record for successfully managing their institutions through economic cycles.“We know that if we take care of our customers, our employees and our communities,...

Recognizes ORBCOMM’s technology leadership and expertise in enabling IoT solutionsROCHELLE PARK, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) — ORBCOMM Inc. (Nasdaq: ORBC), a global provider of Internet of Things (IoT) solutions, today announced that TMC, a global, integrated media company, has named ORBCOMM’s BT 500 in-cab solution as a recipient of the 2020 Unified Communications Excellence Award presented by TMC’s Internet Telephony magazine.Powering ORBCOMM’s truck management solution, the BT 500 enables complete visibility, monitoring and management of drivers, vehicles and displays. Part of a comprehensive solution that combines in-cab devices, powerful cloud-based reporting and connected hardware, the BT 500 provides GPS fleet tracking, advanced data collection from the CANbus, flexible communication options and an open, scalable...

Mason Graphite has an industry-experienced and proven slate of nominees who will represent a refreshed vision for the Company as the Board continues to deliver on its prescient plan surrounding Value-Added Graphite Products.Vote using only Management’s Proxy by December 23, 2020 at 10:00 a.m. (Eastern Time) FOR all of Management’s Nominees.For more information or if you require assistance with voting, contact Mason Graphite’s proxy solicitation agent, Laurel Hill Advisory Group at 1-877-452-7184 or by email at assistance@laurelhill.com. Visit www.masongraphite.com for more information.MONTREAL, Dec. 22, 2020 (GLOBE NEWSWIRE) — Mason Graphite Inc. (“Mason Graphite” or the “Company“) (TSX.V: LLG; OTCQX: MGPHF) would like to thank shareholders for the strong show of confidence they have displayed through their votes...

Mason Graphite présente une liste d’administrateurs nominés éprouvés et expérimentés qui représenteront une vision renouvelée de la Société afin que le Conseil poursuive son plan éclairé autour des produits de graphite à valeur ajoutée.Votez POUR tous les nominés de la Direction en utilisant seulement la procuration de la Direction avant le 23 décembre 2020 à 10 h (heure de l’Est).Pour plus d’information ou pour de l’assistance pour voter veuillez contacter le groupe Laurel Hill, agents de sollicitation de procurations de la Société au 1 877 452-7184 ou par courriel à assistance@laurelhill.com. Rendez-vous sur www.masongraphite.com pour plus d’informations.MONTRÉAL, 22 déc. 2020 (GLOBE NEWSWIRE) — Mason Graphite inc. (« Mason Graphite » ou la « Société ») (TSX.V : LLG; OTCQX : MGPHF) souhaite remercier ses actionnaires pour la confiance...